MCAT Biochemistry: Metabolism (glycolysis, TCA, Oxidative Phosphorylation)
Last updated: May 2, 2026
Biochemistry: Metabolism (glycolysis, TCA, Oxidative Phosphorylation) questions are one of the highest-leverage areas to study for the MCAT. This guide breaks down the rule, the elements you need to recognize, the named traps that catch most students, and a memory aid that scales to test day. Read it once, then practice the same sub-topic adaptively in the app.
The rule
Cellular respiration is one continuous accounting problem: glucose's six carbons leave as $\text{CO}_2$, its electrons travel to $\text{O}_2$ via NADH and FADH2, and the energy released is captured first as a proton gradient and then as ATP. To answer MCAT metabolism questions, track three things in parallel — the carbon path, the electron carrier path, and the ATP/proton path — and remember that everything funnels through three regulated bottlenecks: hexokinase/PFK-1 in glycolysis, pyruvate dehydrogenase at the gate to the TCA cycle, and isocitrate dehydrogenase inside it.
Elements breakdown
Glycolysis (Cytoplasm)
Glucose to two pyruvate, with a net gain of ATP and reduced NAD+, occurring without oxygen.
- Invest 2 ATP in priming steps
- Generate 4 ATP by substrate-level phosphorylation
- Net yield: 2 ATP and 2 NADH per glucose
- Rate-limited by PFK-1, activated by AMP and F2,6BP
- Inhibited allosterically by ATP and citrate
Common examples:
- Hexokinase traps glucose as glucose-6-phosphate
- Pyruvate kinase generates the second substrate-level ATP
Pyruvate Dehydrogenase (PDH) Bridge
Irreversible oxidative decarboxylation linking glycolysis to the TCA cycle inside the mitochondrial matrix.
- Pyruvate $\to$ acetyl-CoA + $\text{CO}_2$
- Generates 1 NADH per pyruvate (2 per glucose)
- Inhibited by acetyl-CoA, NADH, and ATP
- Activated by $\text{Ca}^{2+}$, ADP, and pyruvate
- Requires thiamine, lipoate, FAD, NAD+, CoA
TCA (Citric Acid) Cycle
Acetyl-CoA's two carbons enter, leave as $\text{CO}_2$, and electrons are deposited on NAD+ and FAD.
- Per acetyl-CoA: 3 NADH, 1 FADH2, 1 GTP, 2 $\text{CO}_2$
- Per glucose (2 turns): 6 NADH, 2 FADH2, 2 GTP
- Rate-limited by isocitrate dehydrogenase
- $\text{Ca}^{2+}$ activates 3 mitochondrial dehydrogenases
- NADH/ATP feedback inhibit multiple steps
Electron Transport Chain (ETC)
NADH and FADH2 deliver electrons to a series of complexes in the inner mitochondrial membrane, terminating at $\text{O}_2$.
- NADH enters at Complex I (pumps protons)
- FADH2 enters at Complex II (no pumping)
- Complexes I, III, and IV pump $\text{H}^+$ to intermembrane space
- $\text{O}_2$ is the terminal electron acceptor at Complex IV
- Yields ~2.5 ATP/NADH and ~1.5 ATP/FADH2
Chemiosmosis and ATP Synthase
The proton gradient drives ATP synthesis as $\text{H}^+$ flows back through ATP synthase.
- $\text{F}_0$ channel rotates with proton flow
- $\text{F}_1$ catalytic head phosphorylates ADP
- Oligomycin blocks $\text{F}_0$ channel
- Uncouplers (DNP, thermogenin) dissipate gradient as heat
- ATP/ADP antiporter exports ATP using gradient energy
NADH Shuttles
Cytoplasmic NADH from glycolysis cannot cross the inner mitochondrial membrane and must be shuttled in.
- Malate-aspartate shuttle: regenerates NADH in matrix (~2.5 ATP)
- Glycerol-3-phosphate shuttle: hands off to FAD (~1.5 ATP)
- Tissue-dependent: heart/liver use malate-aspartate, muscle/brain use glycerol-3-P
- Total ATP per glucose: ~32 (malate-aspartate) or ~30 (glycerol-3-P)
Common patterns and traps
The Inhibitor-Site Identification
MCAT passages routinely describe a novel toxin or drug, give you data on $\text{O}_2$ consumption, ATP, membrane potential, and heat, and ask where it acts. The trick is that ETC blockers, ATP synthase blockers, and uncouplers each produce a distinct signature across those four readouts. Memorize the signature table and these problems become recognition tasks rather than reasoning ones.
A choice that names a specific complex or shuttle, framed as the site of action, where you must check whether the data showed $\text{O}_2$ rising or falling and whether membrane potential was preserved or lost.
The ATP-Yield Arithmetic
Yield questions reward students who track each carrier from each stage and apply the modern $\sim$2.5 / $\sim$1.5 conversion. Many wrong answers come from older textbooks (3 ATP/NADH, 2 ATP/FADH2 giving 38), from forgetting to subtract the 2 priming ATP, or from using the wrong NADH shuttle. Read the question for the shuttle hint — "liver," "heart," or "malate-aspartate" means $\sim$32; "muscle," "brain," or "glycerol-3-phosphate" means $\sim$30.
Four nearby integers around 30 (e.g., 30, 32, 36, 38), where the difference between adjacent answers traces directly to a single accounting choice.
The PFK-1 Regulator Override
PFK-1 sits at the metabolic crossroads with at least four allosteric regulators (ATP, AMP, citrate, F2,6BP). Questions stage scenarios where regulators send conflicting signals, and the correct answer identifies which one dominates in that physiological context. F2,6BP — the master signal of fed-state hepatic glycolysis — almost always wins when it appears.
A choice that explicitly names F2,6BP as activating PFK-1 with a stated mechanism, contrasted with choices that mischaracterize it as a substrate, an AMP analog, or as acting solely on the gluconeogenic enzyme.
Substrate-Level vs. Oxidative Phosphorylation Confusion
MCAT items will set up a scenario in which oxygen is unavailable or oxidative phosphorylation is blocked, then ask which steps still produce ATP. Substrate-level phosphorylation (glycolysis steps 7 and 10, succinyl-CoA synthetase in the TCA) is the correct answer because it does not require the gradient. Wrong choices typically conflate "mitochondrial" with "oxidative," missing that succinyl-CoA synthetase is mitochondrial yet substrate-level.
A choice naming a specific enzyme — phosphoglycerate kinase, pyruvate kinase, or succinyl-CoA synthetase — as the source of ATP under hypoxia, set against choices that incorrectly include ATP synthase or Complex IV.
Shuttle-Dependent Yield Variance
The same glucose molecule yields ~32 ATP via the malate-aspartate shuttle but only ~30 via the glycerol-3-phosphate shuttle, because the latter delivers electrons to FAD rather than NAD+. Tissue identity is the cue. Forgetting that the cytoplasmic NADH path matters is one of the most common ATP-yield mistakes.
Two answers that differ by exactly 2 ATP, where the deciding factor is which shuttle the question implies.
How it works
Picture a glucose molecule entering a hepatocyte. Two ATP are spent splitting it; four come back as substrate-level phosphorylation in glycolysis, leaving a net 2 ATP plus 2 cytoplasmic NADH and 2 pyruvates. Each pyruvate crosses into the matrix, loses a $\text{CO}_2$ at PDH (yielding 1 NADH), and the resulting acetyl-CoA enters the TCA cycle to yield 3 NADH, 1 FADH2, 1 GTP, and 2 $\text{CO}_2$ per turn. Now you have 10 NADH and 2 FADH2 carrying the electrons; oxidative phosphorylation converts them to roughly 25 + 3 ATP, and the 2 GTP and 2 net glycolytic ATP bring the total to about 32. If a question swaps in cyanide, oligomycin, or DNP, your job is to identify exactly which step in this chain has been broken and to predict which downstream pools (NADH, $\text{O}_2$ consumption, ATP, gradient, heat) rise or fall.
Worked examples
Dr. Marta Reyes investigated mitochondrial efficiency in cultured hepatocytes treated with compound BX-12, a small lipophilic weak acid. Cells were incubated with $[\text{U-}^{14}\text{C}]$-glucose for 30 minutes under three conditions: (1) untreated control, (2) BX-12 alone, and (3) BX-12 plus oligomycin. Oxygen consumption was measured polarographically and ATP was quantified by luciferase assay. In BX-12-treated cells, oxygen consumption increased 3.4-fold over control while cellular ATP fell to 22% of baseline. Heat production rose sharply, and mitochondrial membrane potential, measured by JC-1 fluorescence, collapsed. Adding oligomycin with BX-12 did not restore membrane potential, and oxygen consumption remained elevated. Reyes proposed that BX-12 acts by a mechanism similar to that of brown-adipose thermogenin (UCP1).
BX-12 most likely produces the observed effects by:
- A Inhibiting cytochrome c oxidase at Complex IV.
- B Shuttling protons across the inner mitochondrial membrane and dissipating the electrochemical gradient. ✓ Correct
- C Blocking the $\text{F}_0$ proton channel of ATP synthase.
- D Inhibiting the malate-aspartate shuttle and trapping NADH in the cytoplasm.
Why B is correct: The fingerprint of an uncoupler is exactly what the passage shows: $\text{O}_2$ consumption rises (ETC runs unrestrained because the gradient is no longer back-pressuring it), ATP collapses (ATP synthase has no gradient to drive it), heat rises (energy dissipates instead of being captured), and membrane potential is lost. Crucially, oligomycin cannot rescue the gradient because protons bypass ATP synthase entirely through BX-12 itself. Reyes's comparison to UCP1 confirms the protonophore mechanism.
Why each wrong choice fails:
- A: Complex IV inhibition would DECREASE $\text{O}_2$ consumption (the ETC stalls because $\text{O}_2$ cannot be reduced), the opposite of the 3.4-fold increase observed. (The Inhibitor-Site Identification)
- C: Blocking $\text{F}_0$ would back up the proton gradient and DECREASE $\text{O}_2$ consumption, and would not collapse membrane potential. The data show elevated $\text{O}_2$ and lost potential, so this contradicts both readouts. (The Inhibitor-Site Identification)
- D: Shuttle inhibition would slightly reduce ATP yield by stranding cytoplasmic NADH but would not collapse membrane potential, drive heat production, or triple $\text{O}_2$ consumption. (Shuttle-Dependent Yield Variance)
A hepatocyte completely oxidizes one molecule of glucose to $\text{CO}_2$ and $\text{H}_2\text{O}$ through glycolysis, pyruvate dehydrogenase, the citric acid cycle, and oxidative phosphorylation. Assume the malate-aspartate shuttle is the active mechanism for cytoplasmic NADH and that mitochondrial yields are $\sim 2.5$ ATP per NADH and $\sim 1.5$ ATP per FADH2.
The approximate net ATP yield per glucose is closest to:
- A 30 ATP
- B 32 ATP ✓ Correct
- C 36 ATP
- D 38 ATP
Why B is correct: Glycolysis nets 2 ATP and produces 2 cytoplasmic NADH that, via malate-aspartate, become 2 mitochondrial NADH ($2 \times 2.5 = 5$ ATP). PDH gives 2 NADH ($5$ ATP). TCA per glucose gives 6 NADH ($15$ ATP), 2 FADH2 ($3$ ATP), and 2 GTP ($2$ ATP). Total: $2 + 5 + 5 + 15 + 3 + 2 = 32$ ATP.
Why each wrong choice fails:
- A: 30 ATP is the yield when the glycerol-3-phosphate shuttle is used (cytoplasmic NADH passes electrons to FAD, losing 1 ATP per NADH = 2 ATP total). The question specifies the malate-aspartate shuttle, so 30 is wrong here. (Shuttle-Dependent Yield Variance)
- C: 36 ATP arises from older partial-conversion factors (e.g., 3 ATP/NADH for mitochondrial NADH but 2 ATP/cytoplasmic NADH). The question explicitly anchors the modern $\sim 2.5 / \sim 1.5$ values. (The ATP-Yield Arithmetic)
- D: 38 ATP is the legacy textbook value using 3 ATP/NADH and 2 ATP/FADH2. The question instructs you to use the lower modern values, which give 32, not 38. (The ATP-Yield Arithmetic)
Dr. Fei Liu studied glycolytic flux in primary hepatocytes from mice with a liver-specific knockdown of fructose-2,6-bisphosphatase 2. Cells were perfused with either 5 mM or 25 mM glucose, and intracellular concentrations of fructose-2,6-bisphosphate (F2,6BP), AMP, citrate, and ATP were measured at steady state. At 25 mM glucose, F2,6BP rose 6-fold, AMP fell 40%, citrate doubled, and ATP rose 25%. Glycolytic flux, measured by lactate production, increased 4-fold. Liu argued that F2,6BP was the dominant signal driving forward flux despite opposing changes in the other allosteric regulators of phosphofructokinase-1 (PFK-1).
Which of the following best supports Dr. Liu's interpretation?
- A F2,6BP is a high-affinity allosteric activator of PFK-1 that overrides the inhibitory signals from elevated citrate and ATP. ✓ Correct
- B F2,6BP is a substrate of PFK-1 in the hepatic isoform and accelerates flux by mass action.
- C F2,6BP binds the same allosteric site as AMP and substitutes for it when AMP levels fall.
- D F2,6BP inhibits fructose-1,6-bisphosphatase, which is sufficient to explain the increase in glycolytic flux through PFK-1.
Why A is correct: F2,6BP is the most potent allosteric activator of liver PFK-1, binding at a site distinct from AMP and capable of overriding ATP- and citrate-mediated inhibition. The passage shows ATP and citrate are elevated (which would normally slow PFK-1), AMP is decreased (which would also reduce activation), and yet flux through glycolysis quadrupled — the only remaining regulator that explains forward flux is the 6-fold rise in F2,6BP, exactly as Liu argues.
Why each wrong choice fails:
- B: PFK-1's substrate is fructose-6-phosphate, not F2,6BP. F2,6BP is a regulator only — calling it a substrate is a fundamental category error and contradicts standard biochemistry. (The PFK-1 Regulator Override)
- C: F2,6BP and AMP bind distinct allosteric sites on PFK-1; they are independent activators, not interchangeable. Also, AMP fell in the experiment, so a fall in AMP cannot itself activate the enzyme. (The PFK-1 Regulator Override)
- D: Inhibiting fructose-1,6-bisphosphatase blocks gluconeogenesis but does not push forward flux through PFK-1. The PFK-1/FBPase-1 substrate cycle is regulated by F2,6BP at both enzymes, but accelerating glycolysis specifically requires PFK-1 activation, which only choice A captures. (The PFK-1 Regulator Override)
Memory aid
"2-2-6-2-2" per glucose: 2 net ATP and 2 NADH from glycolysis, 2 NADH from PDH, 6 NADH from TCA, 2 FADH2 from TCA, 2 GTP from TCA. Then convert: NADH × 2.5, FADH2 × 1.5, plus the substrate-level ATP/GTP.
Key distinction
Inhibiting the ETC (cyanide, antimycin A, rotenone) stops $\text{O}_2$ consumption AND ATP synthesis. Inhibiting ATP synthase (oligomycin) stops ATP synthesis and indirectly stops $\text{O}_2$ consumption because the gradient backs up. Uncouplers (DNP) RAISE $\text{O}_2$ consumption while ATP synthesis collapses — that opposite signature is the dead giveaway.
Summary
Track carbon, electrons, and protons separately through glycolysis, PDH, TCA, and the ETC, and most metabolism questions resolve into a simple flow problem with one broken step.
Practice biochemistry: metabolism (glycolysis, tca, oxidative phosphorylation) adaptively
Reading the rule is the start. Working MCAT-format questions on this sub-topic with adaptive selection, watching your mastery score climb in real time, and seeing the items you missed return on a spaced-repetition schedule — that's where score lift actually happens. Free for seven days. No credit card required.
Start your free 7-day trialFrequently asked questions
What is biochemistry: metabolism (glycolysis, tca, oxidative phosphorylation) on the MCAT?
Cellular respiration is one continuous accounting problem: glucose's six carbons leave as $\text{CO}_2$, its electrons travel to $\text{O}_2$ via NADH and FADH2, and the energy released is captured first as a proton gradient and then as ATP. To answer MCAT metabolism questions, track three things in parallel — the carbon path, the electron carrier path, and the ATP/proton path — and remember that everything funnels through three regulated bottlenecks: hexokinase/PFK-1 in glycolysis, pyruvate dehydrogenase at the gate to the TCA cycle, and isocitrate dehydrogenase inside it.
How do I practice biochemistry: metabolism (glycolysis, tca, oxidative phosphorylation) questions?
The fastest way to improve on biochemistry: metabolism (glycolysis, tca, oxidative phosphorylation) is targeted, adaptive practice — working questions that focus on your specific weak spots within this sub-topic, getting immediate feedback, and revisiting items you missed on a spaced-repetition schedule. Neureto's adaptive engine does this automatically across the MCAT; start a free 7-day trial to see your sub-topic mastery climb in real time.
What's the most important distinction to remember for biochemistry: metabolism (glycolysis, tca, oxidative phosphorylation)?
Inhibiting the ETC (cyanide, antimycin A, rotenone) stops $\text{O}_2$ consumption AND ATP synthesis. Inhibiting ATP synthase (oligomycin) stops ATP synthesis and indirectly stops $\text{O}_2$ consumption because the gradient backs up. Uncouplers (DNP) RAISE $\text{O}_2$ consumption while ATP synthesis collapses — that opposite signature is the dead giveaway.
Is there a memory aid for biochemistry: metabolism (glycolysis, tca, oxidative phosphorylation) questions?
"2-2-6-2-2" per glucose: 2 net ATP and 2 NADH from glycolysis, 2 NADH from PDH, 6 NADH from TCA, 2 FADH2 from TCA, 2 GTP from TCA. Then convert: NADH × 2.5, FADH2 × 1.5, plus the substrate-level ATP/GTP.
What's a common trap on biochemistry: metabolism (glycolysis, tca, oxidative phosphorylation) questions?
Confusing substrate-level phosphorylation with oxidative phosphorylation
What's a common trap on biochemistry: metabolism (glycolysis, tca, oxidative phosphorylation) questions?
Forgetting that FADH2 enters at Complex II and yields fewer ATP than NADH
Ready to drill these patterns?
Take a free MCAT assessment — about 25 minutes and Neureto will route more biochemistry: metabolism (glycolysis, tca, oxidative phosphorylation) questions your way until your sub-topic mastery score reflects real improvement, not luck. Free for seven days. No credit card required.
Start your free 7-day trial